Part D and dually eligible patients with mental illness: medication access problems and use of intensive services.
Part D and dually eligible patients with mental illness: medication access problems and use of intensive services.
复制标题
D 部分和双重资格的精神疾病患者:药物获取问题和强化服务的使用。
DOI:
10.1176/ps.2009.60.9.1169
复制
发表时间:
2009-09
期刊:
影响因子:
--
通讯作者:
Frank RG
中科院分区:
文献类型:
--
作者:
Huskamp HA;West JC;Rae DS;Rubio-Stipec M;Regier DA;Frank RG
This study examined the occurrence of medication access problems and use of intensive mental health services after the transition from Medicaid drug coverage to Part D for dual-eligibles. Psychiatrists randomly selected from American Medical Association’s Physicians Masterfile reported on experiences in the first twelve months of 2006 of one systematically-selected dual-eligible patient (n=908). Propensity score matching was used to compare use of psychiatric emergency room and inpatient care for individuals who experienced a problem accessing a psychiatric medication after Part D and those who did not. Approximately 44% of dual-eligible patients were reported to experience a problem accessing medications. The likelihood of having an emergency room visit was significantly higher for those who experienced a problem compared to those who did not (mean OR=1.75, mean p-value=0.003). There was no difference in number of emergency room visits conditional on emergency room use or in hospitalization use. Many dual-eligible patients experienced difficulty accessing psychiatric medications after Part D’s implementation. Patients who experienced difficulties were significantly more likely to use psychiatric emergency room care than patients who did not experience difficulties. While not definitive evidence of a cost offset onto non-drug health care benefits of the switch to Part D for dual-eligibles, these findings raise concerns about potential offsets and possible negative impacts on quality of care. Additional study is needed to understand the full effects of Part D on outcomes and functioning as well as treatment costs for dual-eligibles.
登录
查看更多内容
影响因子:
9.7
作者:
Neuman, Patricia;Strollo, Michelle Kitchman;Safran, Dana Gelb
通讯作者:
Safran, Dana Gelb
影响因子:
3.8
作者:
Pingitore, DP;Scheffler, RM;West, JC
通讯作者:
West, JC
影响因子:
3.8
作者:
West, Joyce C.;Wilk, Joshua E.;Regier, Darrel A.
通讯作者:
Regier, Darrel A.
影响因子:
3.8
作者:
Weiden, PJ;Kozma, C;Locklear, J
通讯作者:
Locklear, J
影响因子:
--
作者:
Robinson, D;Woerner, MG;Lieberman, JA
通讯作者:
Lieberman, JA